第一单位：
Sorbonne University, INSERM UMR_S_938, Saint-Antoine Research Center (CRSA), Research Department "Cancer, Vessels, Biology and Therapeutics" (CaVITE), Research Group "Cancer-Angiogenesis-Thrombosis and Haemostasis," Thrombosis Center, University Institute of Cancerology (UIC), Saint Antoine University Hospital Assistance Publique Hôpitaux de Paris (AP-HP) Paris France.;VAS-European Independent Foundation in Angiology/Vascular Medicine Milan Italy.
作者：
Grigoris,Gerotziafas [1]
;
Despina,Fotiou [2]
;
Inger,Nijhof [3]
;
Cihan,Ay [4]
;
Ramon,Lecumberri [5]
;
Alessandra,Laroca [6]
;
Gordon,Cook [7]
;
Monika,Engelhardt [8]
;
Sonja,Zweegman [9]
;
Michel,Delforge [10]
;
Anthony,Maraveyas [11]
;
Eleftheria,Lefkou [1]
;
Marina,Marchetti [12]
;
Niels W C J,Van de Donk [9]
;
Francesca,Gay [6]
;
Heinz,Ludwig [13]
;
Hermann,Einsele [14]
;
Jesus F,San Miguel [15]
;
Meletios A,Dimopoulos [16]
;
Mario,Boccadoro [6]
;
Pieter,Sonneveld [17]
;
Anna,Falanga [12]
;
Evangelos,Terpos [2]
作者单位：
Sorbonne University, INSERM UMR_S_938, Saint-Antoine Research Center (CRSA), Research Department "Cancer, Vessels, Biology and Therapeutics" (CaVITE), Research Group "Cancer-Angiogenesis-Thrombosis and Haemostasis," Thrombosis Center, University Institute of Cancerology (UIC), Saint Antoine University Hospital Assistance Publique Hôpitaux de Paris (AP-HP) Paris France.;VAS-European Independent Foundation in Angiology/Vascular Medicine Milan Italy.
[1]
Department of Clinical Therapeutics Plasma Cell Dyscrasias Unit, National and Kapodistrian University of Athens, School of Medicine Athens Greece.
[2]
Department of Hematology Amsterdam University Medical Center Amsterdam The Netherlands.;Department of Internal Medicine St. Antonius Hospital Nieuwegein The Netherlands.;Department of Hematology St. Antonius Hospital Nieuwegein The Netherlands.
[3]
Department of Medicine I, Comprehensive Cancer Center Vienna, Division of Hematology and Hemostaseology Medical University of Vienna Vienna Austria.
[4]
Hematology Service Clínica Universidad de Navarra Pamplona Spain.;CIBERCV, Carlos III Health Institute Madrid Spain.
[5]
Division of Hematology University of Torino, AOU Città della Salute e della Scienza di Torino Torino Italy.
[6]
Leeds Institute of Clinical Trial Research & Leeds Cancer Centre, Leeds Teaching Hospitals NHS Trust Leeds UK.
[7]
Department of Hematology and Oncology, Interdisciplinary Cancer Center and Comprehensive Cancer Center Freiburg, Faculty of Freiburg University of Freiburg Freiburg Germany.
[8]
Department of Hematology Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam Amsterdam The Netherlands.
[9]
Department of Hematology University Hospital Leuven Leuven Belgium.
[10]
Queen's Centre for Oncology and Haematology, Clinical Sciences Centre, Hull York Medical School and Hull University Teaching Hospitals NHS Trust Hull UK.
[11]
Department of Immunohematology and Transfusion Medicine Hospital Papa Giovanni XXIII Bergamo Italy.;Department of Medicine and Surgery University of Milano-Bicocca Monza Italy.
[12]
First Department of Medicine Center for Oncology, Hematology, and Palliative Care, Wilhelminen Cancer Research Institute, Clinic Ottakring Vienna Austria.
[13]
Department of Internal Medicine II University Hospital Wurzburg Wurzburg Germany.
[14]
Clinica Universidad de Navarra, CIMA, IDISNA, CIBERONC Pamplona Spain.
[15]
Department of Clinical Therapeutics Plasma Cell Dyscrasias Unit, National and Kapodistrian University of Athens, School of Medicine Athens Greece.;Department of Medicine Korea University Seoul South Korea.
[16]
Department of Hematology Erasmus MC Cancer Institute Rotterdam The Netherlands.
[17]
DOI
10.1002/hem3.70177
PMID
40880878
发布时间
2025-11-17
换一批
